Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tinostamustine for use in the treatment of T-cell prolymphocytic leukaemia

Tinostamustine for use in the treatment of T-cell prolymphocytic leukaemia

US Patent 11918558 · Granted Mar 5, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hodgkin lymphoma therapy2025
Pharmaceutical combinations for treating cancer2025
Compounds for treating lymphoma or a T-cell malignant disease2025
Compounds for treating brain cancer2025
Tinostamustine for use in the treatment of t-cell prolymphocytic leukaemia2025
Tinostamustine for use in the treatment of t-cell prolymphocytic leukaemia2025
Compounds for treating TNBC2025
Tinostamustine for use in treating sarcoma2025
Combination comprising a glucocorticoid and EDO-S1012024
Pharmaceutical combinations for treating cancer2024
Tinostamustine for use in treating ovarian cancer2024
Compounds for treating TNBC2023